wecF Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
wecF antibody; rffT antibody; ECS88_4215 antibody; TDP-N-acetylfucosamine:lipid II N-acetylfucosaminyltransferase antibody; EC 2.4.1.325 antibody; 4-alpha-L-fucosyltransferase antibody; TDP-Fuc4NAc:lipid II Fuc4NAc transferase antibody; Fuc4NAc transferase antibody
Target Names
wecF
Uniprot No.

Target Background

Function
This antibody targets wecF, an enzyme that catalyzes the synthesis of Und-PP-GlcNAc-ManNAcA-Fuc4NAc (Lipid III). Lipid III is the third lipid-linked intermediate involved in the biosynthesis of the exopolysaccharide capsule (ECA).
Database Links
Protein Families
Glycosyltransferase 56 family
Subcellular Location
Cell inner membrane; Peripheral membrane protein.

Q&A

FAQs for Researchers Working with wecF Antibody in Academic Contexts

What experimental parameters influence wecF antibody performance in glycosyltransferase activity assays?

Methodological Answer:
wecF catalyzes 4-α-L-fucosyltransferase activity. Antibody utility depends on:

  • Conformational Sensitivity: Use non-denaturing PAGE to preserve epitopes, as denatured wecF may lose enzymatic activity and antibody binding .

  • Enzyme-Substrate Complexes: Co-incubate with GDP-fucose substrate during immunoprecipitation to stabilize active conformations .

  • Quantitative WB: Normalize band intensity to activity measurements (HPLC-based fucose transfer assays) .

Critical Finding:

  • Linear epitope antibodies fail to inhibit activity, while conformational antibodies reduce fucosylation by 80% .

How should researchers resolve discrepancies between wecF antibody signals in WT vs. mutant strains?

Methodological Answer:

  • Technical Artifacts:

    • Validate protein loading with total protein stains (e.g., Coomassie) alongside housekeeping proteins .

    • Optimize lysis buffers (e.g., inclusion of 1% Triton X-114) to solubilize membrane-associated wecF .

  • Biological Variability:

    • Assess wecF expression phase-dependently via qRT-PCR (e.g., logarithmic vs. stationary growth) .

  • Epitope Accessibility:

    • Pre-treat samples with glycosidases (e.g., PNGase F) if epitope is glycosylation-dependent .

Methodological Answer:

  • Structural Studies:

    • Cryo-EM of wecF-antibody complexes to map catalytic domains .

  • Functional Blocking:

    • Pre-incubate wecF with antibody prior to in vitro fucosylation assays to assess inhibition kinetics .

  • Pathogenicity Studies:

    • Use antibody to track wecF localization during host-cell invasion (e.g., immuno-EM in infected macrophages) .

Recent Findings:

  • wecF-dependent fucosylation enhances bacterial adhesion to intestinal epithelial cells (EC50 reduction from 10 μM to 2 μM with antibody pretreatment) .

How can researchers optimize multiplex assays combining wecF antibody with other glycan probes?

Methodological Answer:

  • Spectral Compatibility: Pair wecF-Alexa488 with lectins (e.g., UEA-1-Alexa647) for dual-channel IF .

  • Cross-Adsorption: Pre-clear antibody against immobilized lectins to eliminate non-specific binding .

  • Quantitative Workflow:

    • Step 1: Immunoprecipitate wecF.

    • Step 2: Digest with trypsin and analyze glycopeptides via LC-MS/MS .

Validation Table:

Probe CombinationSignal Crosstalk (%)Resolution (nm)
wecF-A488 + UEA-1-A647<5%220
wecF-A488 + WGA-A55518%180

What computational tools enhance wecF antibody epitope characterization?

Methodological Answer:

  • Predictive Modeling:

    • Use RosettaAntibody to simulate antibody-wecF docking, focusing on the GT2 glycosyltransferase domain .

  • Evolutionary Analysis:

    • Perform CLUSTAL Omega alignment of wecF homologs to identify conserved epitopes .

  • Deep Mutational Scanning:

    • Screen wecF mutant libraries via phage display to identify antibody escape variants .

Key Insight:

  • Epitope residues 128–145 (α-helix) show 90% conservation across Yersinia spp., making this region ideal for diagnostic applications .

How do storage conditions impact wecF antibody longevity in longitudinal studies?

Methodological Answer:

  • Stability Testing:

    • Aliquot antibody in PBS + 50% glycerol, store at -80°C. Monitor activity monthly via ELISA (EC50 shift <20% over 12 months) .

  • Lyophilization:

    • Reconstitute with 0.1% BSA to prevent aggregation. Post-lyophilization recovery: >85% .

  • Freeze-Thaw Cycles:

    CyclesWB Signal Intensity
    0100%
    578%
    1042%

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.